Latest Insider Transactions at Humana Inc (HUM)
This section provides a real-time view of insider transactions for Humana Inc (HUM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HUMANA INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HUMANA INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2024
|
Gordon Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
765
+50.0%
|
-
|
|
Sep 01
2024
|
George Renaudin Ii President, Medicare & Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
303
-2.79%
|
$106,656
$352.14 P/Share
|
|
Sep 01
2024
|
George Renaudin Ii President, Medicare & Medicaid |
BUY
Exercise of conversion of derivative security
|
Direct |
1,241
+10.25%
|
-
|
|
Aug 01
2024
|
John Paul W. Felter SVP, Chief Accting Off & Cont. |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-6.83%
|
$22,491
$357.32 P/Share
|
|
Aug 01
2024
|
John Paul W. Felter SVP, Chief Accting Off & Cont. |
BUY
Exercise of conversion of derivative security
|
Direct |
210
+18.53%
|
-
|
|
Aug 01
2024
|
Susan M Diamond Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
142
-0.71%
|
$50,694
$357.32 P/Share
|
|
Aug 01
2024
|
Susan M Diamond Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
311
+1.52%
|
-
|
|
Feb 22
2024
|
William Kevin Fleming Chief Corporate Aff. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,226
-10.61%
|
$448,716
$366.11 P/Share
|
|
Feb 22
2024
|
William Kevin Fleming Chief Corporate Aff. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,566
+23.59%
|
-
|
|
Feb 22
2024
|
Samir Deshpande Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,302
-9.51%
|
$476,532
$366.11 P/Share
|
|
Feb 22
2024
|
Samir Deshpande Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,770
+21.58%
|
-
|
|
Feb 22
2024
|
Bruce D Broussard Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,473
-8.75%
|
$3,101,118
$366.11 P/Share
|
|
Feb 22
2024
|
Bruce D Broussard Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,572
+18.91%
|
-
|
|
Feb 22
2024
|
Vishal Agrawal Chief Strat & Corp Dev Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
959
-8.1%
|
$350,994
$366.11 P/Share
|
|
Feb 22
2024
|
Vishal Agrawal Chief Strat & Corp Dev Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,010
+20.26%
|
-
|
|
Feb 22
2024
|
Timothy S. Huval Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,284
-14.8%
|
$469,944
$366.11 P/Share
|
|
Feb 22
2024
|
Timothy S. Huval Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,712
+29.97%
|
-
|
|
Feb 22
2024
|
Joseph C Ventura Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,153
-14.09%
|
$421,998
$366.11 P/Share
|
|
Feb 22
2024
|
Joseph C Ventura Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,411
+29.43%
|
-
|
|
Feb 22
2024
|
Susan M Diamond Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,125
-15.13%
|
$411,750
$366.11 P/Share
|
|
Feb 22
2024
|
Susan M Diamond Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+31.1%
|
-
|
|
Feb 22
2024
|
George Renaudin Ii President, Medicare & Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
278
-10.49%
|
$101,748
$366.11 P/Share
|
|
Feb 22
2024
|
George Renaudin Ii President, Medicare & Medicaid |
BUY
Exercise of conversion of derivative security
|
Direct |
1,104
+29.4%
|
-
|
|
Feb 21
2024
|
James A. Rechtin President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
4,085
+50.0%
|
-
|
|
Feb 21
2024
|
John Paul W. Felter SVP, Chief Accting Off & Cont. |
BUY
Grant, award, or other acquisition
|
Direct |
490
+40.73%
|
-
|
|
Feb 21
2024
|
William Kevin Fleming Chief Corporate Aff. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,396
+10.64%
|
-
|
|
Feb 21
2024
|
Samir Deshpande Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,464
+9.55%
|
-
|
|
Feb 21
2024
|
Bruce D Broussard Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,786
+16.52%
|
-
|
|
Feb 21
2024
|
Vishal Agrawal Chief Strat & Corp Dev Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,362
+10.01%
|
-
|
|
Feb 21
2024
|
Timothy S. Huval Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,357
+27.06%
|
-
|
|
Feb 21
2024
|
Joseph C Ventura Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,425
+27.87%
|
-
|
|
Feb 21
2024
|
David Dintenfass President, Enterprise Growth |
BUY
Grant, award, or other acquisition
|
Direct |
13,310
+50.0%
|
-
|
|
Feb 21
2024
|
Susan M Diamond Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,480
+40.52%
|
-
|
|
Feb 21
2024
|
George Renaudin Ii President, Medicare & Medicaid |
BUY
Grant, award, or other acquisition
|
Direct |
7,250
+42.97%
|
-
|
|
Feb 21
2024
|
Sanjay K Shetty President, CenterWell |
BUY
Grant, award, or other acquisition
|
Direct |
7,148
+49.42%
|
-
|
|
Feb 20
2024
|
Jorge S. Mesquita Director |
BUY
Open market or private purchase
|
Indirect |
545
+17.45%
|
$200,015
$367.09 P/Share
|
|
Jan 02
2024
|
Jorge S. Mesquita Director |
BUY
Grant, award, or other acquisition
|
Indirect |
430
+17.46%
|
-
|
|
Jan 02
2024
|
John W Garratt Director |
BUY
Grant, award, or other acquisition
|
Direct |
430
+20.33%
|
-
|
|
Dec 15
2023
|
Susan M Diamond Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
684
-5.64%
|
$316,692
$463.58 P/Share
|
|
Dec 15
2023
|
Susan M Diamond Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,467
+10.78%
|
-
|
|
Dec 15
2023
|
Samir Deshpande Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
470
-1.58%
|
$217,610
$463.58 P/Share
|
|
Dec 15
2023
|
Samir Deshpande Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,038
+3.38%
|
-
|
|
Dec 15
2023
|
Timothy S. Huval Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-3.49%
|
$239,371
$463.58 P/Share
|
|
Dec 15
2023
|
Timothy S. Huval Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,111
+6.98%
|
-
|
|
Dec 15
2023
|
William Kevin Fleming Chief Corporate Aff. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
485
-2.03%
|
$224,555
$463.58 P/Share
|
|
Dec 15
2023
|
William Kevin Fleming Chief Corporate Aff. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,054
+4.23%
|
-
|
|
Dec 15
2023
|
Bruce D Broussard Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,730
-1.23%
|
$1,263,990
$463.58 P/Share
|
|
Dec 15
2023
|
Bruce D Broussard Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,935
+3.04%
|
-
|
|
Dec 15
2023
|
John Paul W. Felter SVP, Chief Accting Off & Cont. |
SELL
Payment of exercise price or tax liability
|
Direct |
36
-13.9%
|
$16,668
$463.58 P/Share
|
|
Dec 15
2023
|
John Paul W. Felter SVP, Chief Accting Off & Cont. |
BUY
Exercise of conversion of derivative security
|
Direct |
114
+30.56%
|
-
|